• Korean Journal of Pharmacognosy
• /
• v.40 no.4
• /
• pp.280-285
• /
• 2009

Korean folk medicine 'JoRitDae' has been used mainly to cure vomiting and cancer. With regard to the botanical origin of 'JoRitDae', it has been considered to designate the rhizome of Sasa species (Gramineae), but there was no pharmacognostical confirmation on it. To clarify the botanical origin of 'JoRitDae', the anatomical characteristics of the rhizome of Sasa species growing wild in Korea and Japan, Sasa borealis, S, kurilensis, S. quelpaertensis, S. charatacea and S. senanensis were studied. As a result, it was found the morphological criteria for the five Sasa species that could discriminate them by the number of cell layers in cortex, the ratio of thickness of cortex to rhizome radius, the number of cell layers in the vascular bundle sheath, the total number of vascular bundle and thickness of vascular bundle sheath. According to these criteria, it was clarified that the commercial folk medicine 'JoRitDae' was the rhizome of Sasa borealis.

• Korean Journal of Pharmacognosy
• /
• v.35 no.3 s.138
• /
• pp.215-228
• /
• 2004

The Korean folk medicine 'Jin Hae Cho Ip' has been used as a remedy for neuralgia and as an invigorating drug after a childbirth, etc in Korea. With regard to the botanical origin of 'Jin Hae Cho Ip', several species of Potentilla (Rosaceae) has been refired, but no pharmacognostical study has yet been performed in this regard. To clarify the botanical origin of the 'Jin Hae Cho Ip', the morphological and anatomical characteristics of the leaflets and petioles of Potentilla and Sibbaldia species growing in Korea, such as P. chinensis, P. cryptotaeniae, P. dickinsii, P. discolor, P. fragarioides var. major, P. freyniana, P. kleiniana, P. matsumurae, P. paradoxa, and S. procumbens, were compared. As a result, it was found that 'Jin Hae Cho Ip' was composed of the leaves of P. Chinensis and P. discolor.

• Natural Product Sciences
• /
• v.11 no.1
• /
• pp.22-26
• /
• 2005

Hygrophila auriculata (K. Schum.) Heine is a wild herb commonly found in moist places on the banks of tanks, ditches and paddy fields throughout India and is one of the main sources of Ayurvedic 'Rasayana' drug. The free radical scavenging potential of 50% aqueous alcoholic extract of H. auriculata (HAEt) was studied for DPPH scavenging activity, nitric oxide, hydroxyl radical and ferryl bipyridyl complex scavenging activity along with lipid peroxidation and total antioxidant capacity inhibition using Thiobarbituric acid reactive substances (TBARS) in rat liver homogenate. Integral antioxidative capacity was determined by photochemiluminescence assay. HAEt showed good radical scavenging activity at various concentrations $(200-1000\;{\mu}g/ml)$ against 1,1 diphenyl, 2-picrylhydrazyl (DPPH) (32.32-77.02%) with moderate scavenging activity against Nitric oxide (12.46-52.84%), hydroxyl radical (11.69-55.26%), ferryl bipyridyl complex (17.66-58.67%) and lipid peroxidation (0.829-0.416nmoles/mg protein). The above results indicate HAEt to be very effective antioxidant. It was suggested that the varied therapeutic activities claimed for the plant in the Indian indigenous systems of medicine may be in the part due to the free radical scavenging and/ or potent antioxidant activity.

• Korean Journal of Pharmacognosy
• /
• v.43 no.1
• /
• pp.1-5
• /
• 2012

Korean folk medicine "EJePiNaMu" has been used orally to cure neuralgia, rheumatism and common cold. To clarify the botanical origin of this crude drug, comparative anatomical studies were made on the branches of Zanthoxylum species growing wild in Korea, i.e. Z. coreanum, Z. piperitum, Z. piperitum var. pubescens, Z. planispinum, Z. schinifolium, Z. schinifolium var. inermis, Z. schinifolium var. microphyllum. As a result, it was clarified that "EJePiNaMu" was the branch of Zanthoxylum planispinum.

• Journal of Korean Medical classics
• /
• v.23 no.4
• /
• pp.63-102
• /
• 2010

Purpose : To propose various types of clinical research which is feasible for botanical new drug (IND) development processes, and suggest essential steps to development of study protocol for IND. Methods : Literature-based discussions and one research group's experience is given regarding domestic act, regulation, and system. Results : In order to get an approval of IND for botanical drug in Korea there are several types of clinical research to conduct. In quality control steps for standardized medicinal herbs, case reports or case series can be conducted, and for good manufacturing practice(GMP) steps, we can conduct case reports, case series, and retrospective cohort studies. In addition, as long as we gathered good laboratory practice(GLP) data we can conduct up to quasi-experimental studies and clinical trials including investigator initiated trials. In order to conduct these studies development of study protocol is essential. First, we obtain historical evidence including target disease and indication, efficacy, safety, and endpoints by reviewing medical classics. Second, we obtain clinically and statistically important data by conducting non-clinical studies, observation studies, and quasi-experimental studies. Third, we generate research hypotheses and purposes and explore methodologies, endpoints, clinical practice guidelines, cost-effectiveness, and commercial potential. Finally, we develop study protocol with aid of biostatistician or expert in contract research organization. Discussions and conclusions : This study have obvious limitations in that most thoughts, suggestions, and proposes are from one research group's experience. Therefore, we hope to see various types of research in this topic and process from other research group as well.

• Korean Journal of Pharmacognosy
• /
• v.44 no.4
• /
• pp.313-319
• /
• 2013

A Korean folk medicine, "DangYak (當藥)" has been used as a bitter stomachic in Korea. With regard to the botanical origin of this crude drug, it has been considered to be from Swertia species (Gentianaceae), but there was no pharmacognostical confirmation on it. In this study, the morphological and anatomical characteristics of three Swertia species growing in Korea, Swertia japonica Makino, S. pseudochinensis Hara and S. tetrapetala Pall. were compared to clarify the botanical origin of "DangYak". As a result, it was determined that the commercial "DangYak" from Korean traditional market was proved to be the whole plant body mixture of Swertia japonica and Swertia pseudochinensis.

• Korean Journal of Pharmacognosy
• /
• v.42 no.4
• /
• pp.293-296
• /
• 2011

'JaGuiNaMu' is one of the Korean crude drugs used mainly to cure neuralgia, bone fracture, jaundice, and headache. With regard to the botanical origin of 'JaGuiNaMu', it has been considered to be Albizzia species of Leguminosae, but there was no pharmacognostical confirmation on it. To clarify the botanical origin of 'JaGuiNaMu', the anatomical characteristics of the branch of Albizzia species growing wild in Korea, A. julibrissin and A. coreana were studied. As a result, it was clarified that 'JaGuiNaMu' was the branch of Albizzia julibrissin.

• Korean Journal of Pharmacognosy
• /
• v.41 no.1
• /
• pp.9-13
• /
• 2010

HooBakIp is one of the Korean crude drugs used mainly to cure a headache, apoplexy and dyspepsia. With regard to the botanical origin of HooBakIp, it has been considered to the Machilus thunbergii of Lauraceae in Korea. But there has no pharmacognostical conformation on it. To clarify the botanical origin of HooBakIp, the anatomical characteristics of the leaf of Machilus thunbergii, Machilus thunbergii var. obovata and Machilus japonica were studied. As a result, it was clarified that HooBakIp from Korea was the leaf of Machilus thunbergii.

• Natural Product Sciences
• /
• v.9 no.4
• /
• pp.286-290
• /
• 2003

Ratanjot is attributed to eight species of Boraginacae species belonging to genera Alkanna, Arnebia, Maharanga and Onosma and regarded as one of the important herbal drugs of indigenous systems of medicine. The root and root stock, which form the actual drug, are considered to be an anthelmintic, antipyretic and antiseptic. They are also claimed to be useful in burn, eczema, wounds and eruptions, and used for treating the diseases of eyes, bronchitis, abdominal pains, itch, etc. Several workers reported that the Naphthaquinones (arnebins), the main active constituents of the drug, are responsible for its colour and therapeutic efficacy. It is claimed that the Arnebia nobilis was imported to India from Afghanistan but the red coloured roots resembling with A. nobilis were found to be gathered by local people for commercial purposes during the course of botanical surey of Himalayan region. Hence, it is decided to evaluate Arnebia nobilis pharmacognostically. The important macro-microscopic features of this species are roots 1-5 cm broad; outermost xylem with broad vessels and innermost with groups of radially arranged narrow vessels while the middle region occupied by alternate rings of clusters of broad and narrow vessels and presence of pith. Besides the percentage of arnebin-1, -3 and 4 are 9.37, 10.53 and 1.72 respectively.

• Natural Product Sciences
• /
• v.16 no.2
• /
• pp.107-110
• /
• 2010

Curcuma caesia Roxb. (Zingiberaceae) is commonly known as 'Black turmeric'. In India it grows in West Bengal, Madhya Pradesh, Orissa, Bihar, North-East and Uttar Pradesh and is widely used by ethnic communities for various ailments. Rhizomes of the plant are used for sprains and bruises and are also employed in cosmetics. In West Bengal it is an important place in traditional system of medicine and is also used as a substitute for turmeric in fresh stage. Present communication deals with the detailed pharmacognostical evaluation of the rhizome sample. Inner part of the rhizome is bluish-black in colour and emits a characteristic sweet smell, due to the presence of essential oil. On steam distillation the rhizome yields an essential oil rich in camphor. A detailed HPTLC studies has been carried out for quantitative evaluation of active marker component. HPTLC, physico-chemical, morphological and histological parameters presented in this paper may be proposed as parameters to establish the authenticity of C. caesia rhizome and may possibly help to differentiate the drug from its other allied species.